Chemistry.AI - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeChemistry.AI
Chemistry.AI logo

Chemistry.AI

0 followers

About Chemistry.AI

Chemistry.AI is a platform described for medicinal chemists to evaluate molecular classes and measure brain activity and physiological responses during exposure to molecules, with aims to assess whether a medicinal chemist can sense good versus bad molecules and distinguish human-designed molecules from those generated by artificial intelligence. The project discusses leveraging medicinal chemistry expertise to train and evaluate deep neural networks, and to explore the role of top-performing chemists as discriminators in AI training for pharma applications. It situates itself within the pharmaceutical research landscape, touching on drug discovery and clinical trial prediction concepts, and is associated with Insilico Medicine. The content references operations in Hong Kong and ongoing development across the biomedical AI space.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Gaurab Chakrabarti

CEO, Co-Founder

Sean Hunt

CTO, Co-Founder

Chuck Shehadi

Chief Operating Officer

Carlos Diaz

VP of Global Strategy & International Business

James Begeal

President of Energy & Water

Key Facts

Employees

Unknown

Status

Investor

Investor Type

Venture Investor

Website

https://chemistry.ai